Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 658 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $658 | $N/A | $N/A | $N/A | $10 |
| Non-Current Assets | |||||
| PPE Net | 21 | N/A | N/A | N/A | N/A |
| TOTAL | $21 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $679 | $N/A | $N/A | $N/A | $10 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 267 | 0 | 0 | 0 | 1,360 |
| Accrued Expenses | 360 | N/A | N/A | N/A | 1,060 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,600 |
| TOTAL | $4,627 | $N/A | $N/A | $N/A | $4,590 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,627 | $N/A | $N/A | $N/A | $4,590 |
| Shareholders' Equity | |||||
| Common Shares | 1 | N/A | N/A | N/A | 16,280 |
| Retained earnings | -7,955 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 3,996 | 0 | 0 | 0 | 7,040 |
| TOTAL | $-3,948 | $N/A | $N/A | $N/A | $20,870 |
| Total Liabilities And Equity | $679 | $0 | $0 | $0 | $25,460 |